---
schema_version: "secwatch.filing_event.v1"
accession: "0000950142-22-003344"
form_type: "8-K"
ticker: "VTVT"
cik: "0001641489"
company_name: "vTv Therapeutics Inc."
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:27:19.126057+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# vTv Therapeutics appoints Steven Tuch as CFO, effective Dec 8, 2022

## Summary
- Steven Tuch appointed CFO; base salary $450K, target bonus 40% of salary.
- Tuch granted options for 500K shares vesting over 3 years; performance equity tied to $50M financing.
- Severance: 9 months base salary if terminated without cause or resigns for good reason.
- Tuch previously led Rallybio IPO ($92.7M) and 7 years at BMO Capital Markets.
- Company preparing for Phase 3 trials of lead candidate TTP399 for type 1 diabetes.

## SEC filing metadata
- accession: 0000950142-22-003344
- form_type: 8-K
- ticker: VTVT
- cik: 0001641489
- company_name: vTv Therapeutics Inc.
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1641489/000095014222003344/0000950142-22-003344-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1641489/000095014222003344/eh220309936_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950142-22-003344
- JSON: https://secwatch.observer/filing/0000950142-22-003344.json
- Plain text: https://secwatch.observer/filing/0000950142-22-003344.txt

## Key facts
- Executive change
  Steven Tuch was appointed as Chief Financial Officer at vTv Therapeutics Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: the board of directors of the Company (the “Board”) has appointed Steven Tuch as Chief Financial Officer of the Company, effective as of December 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1641489/000095014222003344/0000950142-22-003344-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.